After a year of controversy and complaints, Sen. Elizabeth Warren is asking a federal watchdog to investigate GSK over its ...
The court directed the firm to pay Ms Gichuki 10 months’ salary as compensation would be adequate in the circumstances ...
GSK’s ViiV Healthcare has shared clinical data on three potential long-acting HIV treatments, providing a look at how its ...
Larson Financial Group LLC cut its holdings in GSK plc (NYSE:GSK – Free Report) by 52.7% during the fourth quarter, according ...
Gilead plans to go straight to Phase III studies for once-yearly lenacapavir, while GSK and Viiv will push forward with their ...
GSK PLC closed 16.86% short of its 52-week high of £18.24, which the company reached on May 16th.
The first designs have been released of the housing-led redevelopment of GlaxoSmithKline’s former west London HQ, drawn up by ...
With Sunday’s Academy Awards ceremony in the rearview mirror, GSK is looking ahead to a potential blockbuster premiere of its ...
It has been about a month since the last earnings report for GSK (GSK). Shares have added about ... up to its next earnings release, or is Glaxo due for a pullback? Before we dive into how ...
Zacks Investment Research on MSN7d
Glaxo (GSK) Up 8% Since Last Earnings Report: Can It Continue?It has been about a month since the last earnings report for GSK (GSK). Shares have added about 8% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback